Log2 fold change (FC) of the overlaps of lipid metabolites between the study groups and those significant metabolites that appear exclusively in a single group (unique) represented... by Laia Bertran (3685147)

Description of fold change of MiR-125b and Lnc THRIL among study groups. by Azza Elamir (13924199)

Subjects:

Demographic, biochemical and clinical characteristics of the study groups. by Azza Elamir (13924199)

Subjects:

Heatmap showing the end motifs of ucfDNA among different groups. by Meihui Chen (1670020)

Subjects:

Homozygous microdeletions of SNPs in the rs58923657 non-risk haplotype result in significantly decreased <i>IKZF1</i> expression and increased proliferation in human LCLs. by Vincent U. Gant (9955199)

Analysis of ucfDNA in DHSs between control and age-comparable bladder cancer groups. by Meihui Chen (1670020)

Subjects:

Overexpression of <i>srgA</i> increases survival 100-fold. by Manon Janet-Maitre (14504859)

Subjects:

Fold changes were calculated as mean condition B/mean condition A, after mTIC normalization. by Manuel A. Cornejo (11636656)

Subjects:

Relations between Lnc THRIL and MiR-125b and clinical data in UC patients. by Azza Elamir (13924199)

Subjects:

Correlations of Lnc THRIL and MiR 125b with study parameters among UC patients. by Azza Elamir (13924199)

Subjects:

Receiver operating characteristic of sensitivity and specificity of Lnc THRIL and MiR-125b in CD patients vs. controls. by Azza Elamir (13924199)

Subjects:

Relations between Lnc THRIL and MiR-125b and clinical data in CD patients. by Azza Elamir (13924199)

Subjects:

Receiver operating characteristic of sensitivity and specificity of Lnc THRIL and MiR-125b in UC patients vs. controls. by Azza Elamir (13924199)

Subjects:

Correlations of Lnc THRIL and MiR 125b with study parameters among CD patients. by Azza Elamir (13924199)

Subjects:

Receiver operating characteristic of sensitivity and specificity of Lnc THRIL and MiR-125b in UC vs. CD patients. by Azza Elamir (13924199)

Subjects:

Supplemental Figure 2: Fold change of HOX genes in NULL compared to WT. Red dots indicate statistically significant increase. by Jeffery Joll (13029351)

“…<p>Fold change increases of Hox genes are compared between NULL and WT groups in the aortic root. …”

Summary of Biomarker Expression in Benign Samples. The STT and LTT groups exhibit significant changes in biomarker expression compared to the nontreatment group, measured on a two-... by Jinho Lee (587173)

Subjects:

Gene expression of CD14+ leucocytes following elective percutaneous coronary intervention, showing the change in gene expression (fold change compared to baseline) of CD14+ leucocy... by Ioannis Merinopoulos (11106088)

Subjects:

Boxplots of morphological parameters between racial groups. by Zoë Dinkel (21402766)

Subjects:

Summary of mean FB ratio distribution across racial groups. by Zoë Dinkel (21402766)

Subjects: